Previous Article | Next Article 
Infection and Immunity, July 2000, p. 4349-4353, Vol. 68, No. 7
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Adjuvant Activity of a Nontoxic Mutant of Escherichia
coli Heat-Labile Enterotoxin on Systemic and Mucosal Immune
Responses Elicited against a Heterologous Antigen Carried by a Live
Salmonella enterica Serovar Typhimurium Vaccine
Strain
Heloisa C. R.
Guillobel,1,2,3
Joana
I.
Carinhanha,1
Lucia
Cárdenas,4
John D.
Clements,4
Darcy F.
de Almeida,1 and
Luís C. S.
Ferreira1,*
Laboratório de Fisiologia Celular, Instituto de
Biofisica Carlos Chagas Filho, CCS, Universidade Federal do Rio de
Janeiro, 21941-590 Rio de Janeiro,1
Departamento de Biofisica e Biometria, Instituto de Biologia,
Universidade do Estado do Rio de Janeiro, 20551-030 Rio de
Janeiro,2 and Departamento de
Genética, Instituto de Biologia, CCS, Universidade Federal do
Rio de Janeiro, 21944-970 Rio de Janeiro,3 Brazil,
and Department of Microbiology and Immunology, Tulane
University Medical Center, School of Medicine, New Orleans,
Louisiana 701124
Received 28 December 1999/Returned for modification 10 February
2000/Accepted 4 April 2000
Systemic and mucosal antibody responses against both the major
subunit of colonization factor antigen I (CFA/I) of enterotoxigenic Escherichia coli (ETEC) and the somatic lipopolysaccharide
expressed by recombinant bivalent Salmonella vaccine
strains were significantly enhanced by coadministration of a detoxified
derivative with preserved adjuvant effects of the ETEC heat-labile
toxin, LT(R192G). The results further support the adjuvant
effects of LT(R192G) and represent a simple alternative to
improve responses against passenger antigens expressed by orally
delivered Salmonella vaccine strains.
*
Corresponding author. Present address: Departamento de
Microbiologia, Universidade de São Paulo, Institute of Biomedical Sciences-ICB II, Av. Prof. Lineu Prestes, 1374-1st Fl. São
Paulo, 05508-900, Brazil. Phone: 5521-560-8093. Fax: 5521-280-8193. E-mail: lcsf{at}biof.ufrj.br.
Infection and Immunity, July 2000, p. 4349-4353, Vol. 68, No. 7
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Turner, A. K., Beavis, J. C., Stephens, J. C., Greenwood, J., Gewert, C., Thomas, N., Deary, A., Casula, G., Daley, A., Kelly, P., Randall, R., Darsley, M. J.
(2006). Construction and Phase I Clinical Evaluation of the Safety and Immunogenicity of a Candidate Enterotoxigenic Escherichia coli Vaccine Strain Expressing Colonization Factor Antigen CFA/I. Infect. Immun.
74: 1062-1071
[Abstract]
[Full Text]
-
Glynn, A., Roy, C. J., Powell, B. S., Adamovicz, J. J., Freytag, L. C., Clements, J. D.
(2005). Protection against Aerosolized Yersinia pestis Challenge following Homologous and Heterologous Prime-Boost with Recombinant Plague Antigens. Infect. Immun.
73: 5256-5261
[Abstract]
[Full Text]
-
Aloni-Grinstein, R., Gat, O., Altboum, Z., Velan, B., Cohen, S., Shafferman, A.
(2005). Oral Spore Vaccine Based on Live Attenuated Nontoxinogenic Bacillus anthracis Expressing Recombinant Mutant Protective Antigen. Infect. Immun.
73: 4043-4053
[Abstract]
[Full Text]
-
Lasaro, M. O., Luiz, W. B., Sbrogio-Almeida, M. E., Nishimura, L. S., Guth, B. E. C., Ferreira, L. C. S.
(2004). Combined Vaccine Regimen Based on Parenteral Priming with a DNA Vaccine and Administration of an Oral Booster Consisting of a Recombinant Salmonella enterica Serovar Typhimurium Vaccine Strain for Immunization against Infection with Human-Derived Enterotoxigenic Escherichia coli Strains. Infect. Immun.
72: 6480-6491
[Abstract]
[Full Text]
-
Sbrogio-Almeida, M. E., Mosca, T., Massis, L. M., Abrahamsohn, I. A., Ferreira, L. C. S.
(2004). Host and Bacterial Factors Affecting Induction of Immune Responses to Flagellin Expressed by Attenuated Salmonella Vaccine Strains. Infect. Immun.
72: 2546-2555
[Abstract]
[Full Text]
-
Smith, D. J., King, W. F., Barnes, L. A., Trantolo, D., Wise, D. L., Taubman, M. A.
(2001). Facilitated Intranasal Induction of Mucosal and Systemic Immunity to Mutans Streptococcal Glucosyltransferase Peptide Vaccines. Infect. Immun.
69: 4767-4773
[Abstract]
[Full Text]
-
Gerber, S., Lane, C., Brown, D. M., Lord, E., DiLorenzo, M., Clements, J. D., Rybicki, E., Williamson, A.-L., Rose, R. C.
(2001). Human Papillomavirus Virus-Like Particles Are Efficient Oral Immunogens when Coadministered with Escherichia coli Heat-Labile Enterotoxin Mutant R192G or CpG DNA. J. Virol.
75: 4752-4760
[Abstract]
[Full Text]